&Partners’s First Trust Mid Cap Value AlphaDEX Fund FNK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$846K Buy
13,802
+8,036
+139% +$478K ﹤0.01% 1519
2026
Q1
$329K Sell
5,766
-636
-10% -$37.2K ﹤0.01% 1933
2025
Q4
$356K Sell
6,402
-370
-5% -$20.3K ﹤0.01% 1810
2025
Q3
$374K Buy
6,772
+7
+0.1% +$381 ﹤0.01% 1630
2025
Q2
$350K Sell
6,765
-1,020
-13% -$50.2K ﹤0.01% 1542
2025
Q1
$390K Buy
7,785
+1,836
+31% +$97.2K ﹤0.01% 1258
2024
Q4
$320K Buy
+5,949
New +$327K ﹤0.01% 1305

Other funds holding FNK

&Partners's FNK Position: Q2 2026 in Review

&Partners increased its First Trust Mid Cap Value AlphaDEX Fund (FNK) stake by 139% in Q2 2026, buying an estimated $478K and bringing the position to 13,802 shares worth $846K. The position accounts for ﹤0.01% of the portfolio, ranked #1519.

&Partners first reported a position in FNK in Q4 2024 and has held it in 7 quarters since. 58 funds tracked by Wall St. Rank hold FNK as of Q2 2026.

  • &Partners held 13,802 shares of First Trust Mid Cap Value AlphaDEX Fund worth $846K as of Q2 2026.
  • &Partners bought 8,036 First Trust Mid Cap Value AlphaDEX Fund shares in Q2 2026, an estimated $478K.
  • First Trust Mid Cap Value AlphaDEX Fund made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1519 holding.
  • &Partners first reported a position in First Trust Mid Cap Value AlphaDEX Fund in Q4 2024 and has held it in 7 quarters since.
  • 58 funds tracked by Wall St. Rank held First Trust Mid Cap Value AlphaDEX Fund as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.